NFE2L2 and hepatocellular carcinoma: Importantly, loss of miR-222 resulted also in down-regulation of the NIK (MAP3K14) – non-canonical NF-kB signalling that mediates expression of HCC driver NRF2 (NFE2L2) [30,31].